ANTIBODY MEDIATED REJECTION OF LUNG TRANSPLANT

Clinical trials for ANTIBODY MEDIATED REJECTION OF LUNG TRANSPLANT explained in plain language.

Never miss a new study

Get alerted when new ANTIBODY MEDIATED REJECTION OF LUNG TRANSPLANT trials appear

Sign up with your email to follow new studies for ANTIBODY MEDIATED REJECTION OF LUNG TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for lung transplant patients battling deadly rejection

Disease control Recruiting now

This early-stage trial is testing whether adding a new medication called siltuximab to standard treatment is safe for lung transplant patients experiencing antibody-mediated rejection. The study will enroll 30 hospitalized adults who have recently been diagnosed with this type of…

Matched conditions: ANTIBODY MEDIATED REJECTION OF LUNG TRANSPLANT

Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

ANTIBODY MEDIATED REJECTION OF LUNG TRANSPLANT

Get alerted when new ANTIBODY MEDIATED REJECTION OF LUNG TRANSPLANT trials appear

New hope for lung transplant patients battling deadly rejection